Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

OTC labeling regs packaging changes would cost industry over $1 bil., NDMA estimates.

This article was originally published in The Tan Sheet

Executive Summary

OTC LABELING PACKAGING CHANGES WOULD COST INDUSTRY OVER $1 BIL., NDMA estimates in comments on FDA's proposed labeling requirements for OTC drugs submitted to the agency Oct. 6. Citing the "substantive" labeling requirements being proposed, the Nonprescription Drug Manufacturers Association says in addition to labeling changes, physical alterations to the packaging of a large number of products would be necessary to comply with the reg. Based on a survey of its members, NDMA estimates the total cost to industry of changing packaging to accommodate the proposed rule would surpass $1 bil.

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

PS087645

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel